Vertical scar breast reduction evidence concerns a family of reduction mammaplasty techniques that usually leave a scar around the areola and a vertical scar to the breast crease, rather than adding a long horizontal crease scar. Often called a “lollipop” pattern, the approach is closely associated with Madeleine Lejour’s work on vertical mammaplasty. It is not a cosmetic shortcut: it is a way of removing tissue, moving the nipple–areola complex on a vascular pedicle, reshaping the remaining gland and managing the skin envelope. Whether it is appropriate depends on breast size, ptosis, skin quality, tissue distribution, the planned reduction and the surgeon’s judgement.
This review examines the vertical scar breast reduction evidence for cosmetic and functional reduction mammaplasty. It explains how the Lejour approach developed, why its shaping logic differs from a Wise-pattern or inverted-T reduction, and what comparative studies can and cannot establish. It does not promise a smaller scar, lower complication rate, preserved sensation, breastfeeding ability or a particular breast shape for every person. Reconstruction, mastopexy without a reduction, augmentation and revision populations have different starting conditions and are not used here as interchangeable evidence.
What “vertical scar” means in reduction mammaplasty
Scar pattern and internal technique are related but not identical. A vertical-scar reduction typically uses a periareolar incision and a vertical limb from the lower edge of the areola to the inframammary fold. Tissue can be removed from selected central, lower or lateral areas; the nipple–areola complex remains attached to a pedicle carrying blood supply and nerves; and the remaining gland is shaped before the skin is closed. The final scar may be limited to the areola and vertical limb, but a short horizontal extension, often called a J or L, may be added when the lower-pole skin envelope requires it.
The contrast is usually made with the Wise pattern, which adds a horizontal scar in the crease and creates an inverted-T or anchor-shaped closure. Neither label tells the whole operative story. Pedicle choice, amount and distribution of resection, skin quality, asymmetry, smoking status, body mass index, prior surgery and the surgeon’s experience all influence risk and shape. A vertical scar is therefore not proof of a particular pedicle or a guarantee that an operation is “less invasive.”
Lejour’s contribution: shape supported by gland, not by skin alone
Vertical reduction ideas pre-date any one surgeon, but Lejour’s descriptions in the early 1990s helped establish a reproducible approach that paired an upper pedicle for the areola with central reduction, limited skin undermining and glandular suturing. In her 1994 series, she described using adjustable markings and creating breast shape through internal glandular sutures rather than relying on a broad skin resection to hold the mound. Liposuction was used selectively in the lateral breast in that report. This was a technical rationale and a personal consecutive series, not randomized evidence that the method is superior for every breast.
The conceptual shift matters. Traditional reduction patterns can remove a large amount of skin and close along a long inframammary line. Vertical methods accept temporary lower-pole skin gathering or “pleating” after closure; the skin is expected to redistribute as swelling falls and the breast settles. That early wrinkling can be alarming if it has not been discussed, and it may persist or need adjustment in some patients. Internal parenchymal shaping aims to create projection and avoid letting skin tension alone determine breast form, but living tissue and skin do not behave identically in every patient.
Lejour’s later appraisal of late results and subsequent modifications show why a named technique should not be treated as a frozen recipe. Surgeons have adapted markings, pedicles, resection patterns, liposuction use, pillars and skin management. When a study says “vertical reduction,” readers should ask which version was used, who performed it and whether conversions or horizontal extensions were reported. Otherwise, a label can hide clinically important variation.
The skin envelope is a practical limit, not a failure of planning
A reduction operation has to reconcile a smaller gland with a skin envelope that was stretched around a larger breast. In a vertical design, the vertical closure redistributes the lower-pole skin. If there is too much horizontal skin excess, forcing everything into a vertical closure can leave puckering, a boxy lower pole, dog-ears, persistent folds or an unsatisfactory breast-to-chest relationship. A short J or L extension—or an inverted-T pattern—may offer more controlled skin removal in a particular breast. This is a reason to individualise the scar plan, not evidence that one pattern is inherently better.
Magnitude of reduction is only one part of the decision. A person seeking a modest reduction may still have substantial lower-pole skin laxity, marked asymmetry or a fold that needs careful management. Conversely, a larger resection does not automatically preclude a vertical approach in experienced hands. What matters is the relationship among base width, skin elasticity, ptosis, breast density, nipple position, desired proportion and safety of the pedicle. Preoperative drawings are a plan, not a binding prediction of the exact scar length or shape once the tissues are assessed during surgery.
Weight change, pregnancy, ageing, genetics and skin quality can alter shape after any reduction. A scar pattern cannot permanently stop ptosis or guarantee upper-pole fullness. The article on the evolution of breast reduction surgery places these design choices in their historical context, while the Wise-pattern and inverted-T evidence review explains why a horizontal crease scar remains useful in some operations.
What comparative evidence says about complications
The most direct comparison is a 2021 systematic review and meta-analysis by Li and colleagues. It included two randomized trials and nine observational comparative studies of vertical-scar versus inverted-T reduction mammaplasty. The pooled analysis reported fewer overall complications and fewer wound-dehiscence events with the vertical-scar approach, while it did not find statistically significant differences for seroma, hematoma, nipple necrosis, fat necrosis or reoperation. Those findings are useful, but they should be read as an association across heterogeneous studies rather than a universal rule for technique selection.
Why the caution? The available studies span different decades, resection sizes, pedicles, definitions of “complication,” follow-up periods and surgeon practices. Patients are often not randomly assigned to scar pattern: a surgeon may select an inverted-T approach for greater skin excess, more severe ptosis, larger or more complex reductions, or a breast with demanding asymmetry. That selection can make one group appear to have more events even when the scar pattern is not the cause. Conversely, a surgeon highly experienced with one technique may achieve results that cannot be transferred simply by copying the incision diagram.
The meta-analysis did include randomized evidence, which is valuable, but two trials cannot eliminate the limitations of the wider evidence base. Complications also depend on patient factors. A 2025 systematic review and meta-analysis of risk factors after reduction mammaplasty highlighted the importance of patient-level variables and incomplete reporting across the literature; it concluded that no single technique fits every patient. This is why a quoted pooled odds ratio should never become a promise that a vertical scar will mean uncomplicated healing.
Wound healing deserves especially careful communication. The junctions of incisions, tissue perfusion, tension, smoking or nicotine exposure, diabetes, BMI, infection risk, blood supply to the nipple–areola complex and postoperative care all matter. A lower average rate of dehiscence in a pooled comparison does not mean dehiscence cannot occur. New spreading redness, fever, drainage, a sudden asymmetric swelling, worsening pain or a darkening nipple–areola complex needs prompt clinical assessment rather than online interpretation.
Quality of life and appearance are separate outcomes
A scar pattern can be aesthetically important, but it should not become the only outcome that matters. In a randomized trial of 255 patients, Thoma and colleagues compared vertical-scar and inverted-T reductions and measured health utility, general health-related quality of life, breast-related symptoms and body image before surgery and at several postoperative points. Both groups had clinically important improvement by one year, and the study found no meaningful difference between techniques in the change in the quality-of-life measures. This supports a modest conclusion: for the people studied, both approaches could be associated with improved symptoms and quality of life, without showing that one pattern delivers a superior patient-reported result.
More recent patient-reported research reinforces the need to separate questions. The BREAST-Q measures domains such as physical, psychosocial and sexual well-being and satisfaction with breasts; it does not reduce success to one “total” score. Observational comparisons can suggest patterns, but they may be influenced by baseline severity, resection amount, practice setting and which questionnaire domains were reported. The BREAST-Q and quality-of-life evidence review for breast reduction discusses those outcomes in depth. Its findings should not be borrowed to promise a certain scar, sensation or contour.
Sensation, breastfeeding and nipple viability: important, incompletely predictable outcomes
Vertical reduction is sometimes presented as though it automatically protects nipple sensation or breastfeeding. That is too strong. Sensation depends on nerve pathways, tissue resection, pedicle design, stretching, swelling, scarring and healing. Breastfeeding potential depends on the preservation of ducts and functional glandular connections as well as factors unrelated to the operation. A pedicle-based technique may be selected with preservation in mind, but no scar pattern by itself can guarantee either outcome.
Nipple–areola viability is also a safety issue rather than a marketing point. Pedicle length and thickness, tissue tension, vascular anatomy, the size of the breast, prior scars and patient risk factors influence perfusion. In an extreme reduction, a surgeon may discuss alternatives such as a free nipple graft because it changes the vascular problem, but it also carries major trade-offs for sensation, pigmentation, projection and breastfeeding. That distinct choice is covered in the free nipple graft evidence review; it should not be conflated with a routine vertical reduction.
How patient selection should be discussed
A responsible consultation begins with symptoms, goals and measurements, not a promise of a “lollipop” scar. The surgeon assesses breast volume and density, degree and pattern of ptosis, lower-pole skin quality, breast-base width, asymmetry, nipple position, inframammary folds, chest-wall shape and any previous breast surgery. Health history includes medicines, diabetes, clotting or bleeding concerns, nicotine use and plans for future weight change or pregnancy. The discussion should also cover what a patient is willing to trade: a potentially shorter crease scar may be less important than predictable skin management, while another person may place high value on avoiding a long horizontal line if anatomy permits.
Photographs, bras, sizing examples and three-dimensional images can aid communication, but they cannot prove the final shape or scar behaviour. Cup size is not a reliable surgical endpoint because bra sizing varies and a reduction changes volume, envelope and proportion. It is reasonable to ask a surgeon why a vertical, J/L or inverted-T pattern is recommended, what may make the plan change during surgery, how often that surgeon uses the technique and how revisions are handled. It is not reasonable to expect a clinical answer to eliminate all uncertainty.
For plain-language procedural context, see the breast reduction operation guide. The breast reduction package page describes service logistics for readers who want them; this evidence review does not compare prices, travel arrangements, hotels, transfers or package options.
Limits of the evidence
Evidence about vertical and Lejour reductions is more informative than a collection of before-and-after photographs, but it remains limited. Much of the comparative literature is retrospective or observational. Technique names are inconsistently defined; operation details and learning curves are often underreported; sample sizes may be modest; and complication definitions can differ. Follow-up may be too short to assess scar maturation, recurrent ptosis, late asymmetry, breastfeeding experience or the need for revision. Results from a specialist centre may not represent every setting.
Publication bias is another concern: distinctive results and favourable cosmetic series may be more likely to appear in print. Patient-reported measures are stronger when collected prospectively with clear response rates, baseline scores and complete domain reporting, yet such reporting is not universal. Studies also rarely isolate scar pattern from every other changing variable. The fairest conclusion is that vertical reduction is an established, adaptable option with a credible rationale and useful comparative data—not a technique that is automatically safer, more durable or more aesthetic for every person.
Conclusion
Vertical scar breast reduction evidence supports vertical mammaplasty as a well-established approach for selected reduction patients. Lejour’s contribution was to foreground glandular shaping, limited skin undermining and the possibility of a shorter scar pattern, while accepting that skin must redrape over time. Comparative evidence suggests that vertical and inverted-T techniques can both provide meaningful benefit; one meta-analysis found lower pooled overall complications and dehiscence with vertical scars, but its heterogeneous and partly observational foundation prevents a universal claim.
The best scar pattern is therefore a patient-specific surgical decision. It should be chosen after an examination and a discussion of tissue, skin envelope, pedicle safety, goals, likely scars, alternatives and uncertainty. A trustworthy plan makes the possible advantages visible without disguising the limitations, and treats wound healing, sensation, breastfeeding, symmetry and long-term shape as outcomes to discuss—not promises to sell.
Frequently asked questions
What is a Lejour breast reduction?
Lejour vertical mammaplasty is a family of breast-reduction techniques that uses a vertical scar pattern, an areolar pedicle and internal glandular shaping. Modern surgeons may use modifications, so the name alone does not specify every operative step.
Is a vertical-scar reduction always better than an inverted-T reduction?
No. A 2021 meta-analysis found lower pooled overall complications and wound dehiscence with vertical scars, but studies differed in patient selection and technique. The pattern should be selected for anatomy, skin excess, safety and the surgeon’s judgement rather than a universal ranking.
Can a vertical reduction be used for a large breast reduction?
It can be considered in some larger reductions, but suitability cannot be decided from size alone. Skin quality, ptosis, tissue distribution, pedicle safety and the amount of horizontal skin excess matter. A J/L extension or inverted-T may be more appropriate in some cases.
Does a lollipop scar mean there will be no scar in the breast crease?
A standard vertical pattern usually avoids a long horizontal crease scar, but some operations need a short horizontal extension to manage skin excess. Scar plans can also change during surgery when tissue and safety are assessed.
Will a vertical technique preserve nipple sensation or breastfeeding?
No technique can guarantee either outcome. Pedicle design may be chosen to preserve blood supply, nerves and ducts where possible, but sensation and breastfeeding depend on several surgical, biological and healing factors.
How long does the breast shape take to settle after vertical reduction?
There is no fixed timetable. Swelling, lower-pole skin gathering and scar maturation change over time and vary between people. Your operating surgeon should give individual follow-up advice and assess concerns such as delayed healing or asymmetry.
Sources and references
- Lejour M. Vertical mammaplasty and liposuction of the breast, 1994. Foundational description of adjustable markings, upper pedicle, central reduction and glandular shaping. PMID: 8016222; DOI: 10.1097/00006534-199407000-00010.
- Lejour M. Vertical mammaplasty: update and appraisal of late results, 1999. Later single-surgeon experience and technical appraisal. PMID: 10456530.
- Li et al. Vertical Scar Versus Inverted-T Scar Reduction Mammaplasty: A Meta-Analysis and Systematic Review, 2021. Two randomized trials and nine observational comparative studies; results must be read with heterogeneity and selection limits in mind. PMID: 33649925; DOI: 10.1007/s00266-021-02167-w.
- Thoma et al. Randomized controlled trial comparing health-related quality of life in vertical scar versus inverted-T reduction mammaplasty, 2013. One-year quality-of-life comparison. PMID: 23806954; DOI: 10.1097/PRS.0b013e3182910cb0.
- Liao et al. Are Surgical Approaches Correlated With BREAST-Q Score Improvements After Reduction Mammaplasty?, 2023. Patient-reported-outcome context and limits of technique comparisons. PMID: 36913563.
- Risk factors for complications after reduction mammaplasty: a systematic review and meta-analysis, 2025. Patient-level risk-factor and reporting-limit context. PMCID: PMC12128374.
- American Society of Plastic Surgeons: Breast Reduction Risks and Safety. Professional-society patient-safety context; not a substitute for an individual clinical assessment.
Author and medical-review metadata
Author: BreastAugmentationInTurkey.org Editorial Team
Medical reviewer: Independent qualified plastic and reconstructive surgeon — medical reviewer to be confirmed before publication
Published: 11 September 2026
Evidence updated: 11 September 2026
Scope: Reduction mammaplasty evidence; reconstruction, augmentation, mastopexy without reduction and revision data are not used as direct predictions.
Editorial limitation: Comparative studies can inform a discussion of scar patterns but cannot guarantee a complication rate, scar behaviour, sensation, breastfeeding outcome or final breast shape for an individual.